Although the FDA approved semaglutide for weight loss in 2021, this medications use in treating type 2 diabetes and heart disease dates back to Ozempics2017 approvalfor reducing the risk of heart attack, stroke, or death in people with type 2 diabetes
The physiological role of ACE2 is to lower blood pressure and counteract inflammation by decreasing the pro-inflammatory mediator angiotensin (17) (ref
Common side effects of GLP-1 drugs include nausea, diarrhea, vomiting and dizziness
SGLT2 inhibitors remain first-line therapies for renal protection in patients with diabetes
Clear evidence of Revita activity: The study met its 3-month efficacy endpoint with strong statistical significance (p=0.014), delivering 2.5% further weight loss with Revita (n=29) even after stopping tirzepatide, versus 10% weight regain in sham-treated patients (n=16)
GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: novel therapeutic agents for metabolic dysfunction-associated steatohepatitis